Company Search:
Advanced Search
Sponsored Links
Proteon Therapeutics Inc Company Snapshot
Proteon Therapeutics Inc operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Proteon Therapeutics Inc with three other companies in this sector in the United States: Windtree Therapeutics Inc (2014 sales of $2.84 million of which 100% was Respiratory Therapies), Titan Pharmaceuticals Inc ($3.65 million of which 100% was Development of Pharmaceutical Products), and Mymetics Corporation ($3.17 million ).

Sales Analysis.
  Stock Performance Chart for Proteon Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 2.50
(Figures in U.S. Dollars)
1 Week 31.6%   13 Weeks 35.1%  
4 Weeks 11.1%   52 Weeks 25.0%  
Proteon Therapeutics Inc Key Data:
  Ticker: PRTO Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2014 Sales 2,948,000
(Year Ending Jan 2015).
Employees: N/A
  Currency: U.S. Dollars Market Cap: 44,048,545
  Fiscal Yr Ends: December Shares Outstanding: 17,619,418
  Share Type: Ordinary Closely Held Shares: 1,844,281
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.